813 related articles for article (PubMed ID: 6119184)
1. [Acid anti-secretion therapy in gastric and duodenal ulcer].
Lattanzi A
Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184
[No Abstract] [Full Text] [Related]
2. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.
Giacosa A; Cheli R; Molinari F; Parodi MC
Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138
[TBL] [Abstract][Full Text] [Related]
3. [Which drug for peptic ulcer?].
Hameeteman W; Tytgat GN
Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
[No Abstract] [Full Text] [Related]
4. [Duodenal ulcer - conservative treatment, success and limitations].
Demling L; Lux G
Chirurg; 1982 Jan; 53(1):1-8. PubMed ID: 6120799
[No Abstract] [Full Text] [Related]
5. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
Simon B; Müller P; Dammann HG
Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
[TBL] [Abstract][Full Text] [Related]
6. New drugs. H2 receptor antagonists--cimetidine and ranitidine.
Feely J; Wormsley KG
Br Med J (Clin Res Ed); 1983 Feb; 286(6366):695-7. PubMed ID: 6130817
[No Abstract] [Full Text] [Related]
7. Ulcer disease of the upper gastrointestinal tract.
Meeroff JC
Hosp Pract (Off Ed); 1984 Oct; 19(10):177-80, 190, 192 passim. PubMed ID: 6148348
[No Abstract] [Full Text] [Related]
8. Famotidine in the USA: a review of efficacy studies.
Gitnick G
J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539
[TBL] [Abstract][Full Text] [Related]
9. [A new H2-receptor antagonist in the treatment of gastrointestinal diseases].
Senfft U
Med Welt; 1982 Oct; 33(43):1516-8. PubMed ID: 6130463
[No Abstract] [Full Text] [Related]
10. [Results of a controlled comparative study between cimetidine and pirenzepin in 60 patients with ulcera ventriculi or duodeni].
Mittelstaedt A; Zilly A; Verhoeven A; Mielenz H
Fortschr Med; 1981 Nov; 99(42):1764-8. PubMed ID: 7030892
[No Abstract] [Full Text] [Related]
11. Pharmacologic options for the control of peptic ulcer disease.
Levine JB
Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
[No Abstract] [Full Text] [Related]
12. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Hentschel E
Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
[No Abstract] [Full Text] [Related]
13. Another look at peptic ulcer.
Piper DW; Barr GD
Aust Fam Physician; 1981 Aug; 10(8):636-40. PubMed ID: 6117272
[No Abstract] [Full Text] [Related]
14. [Clinical trials in the therapy of peptic ulcer. 3. Ambulatary therapy of uncomplicated duodenal ulcer with diverse anticholinergic agents].
Gütz HJ; Berndt H; Wolff G
Dtsch Gesundheitsw; 1970 Mar; 25(12):533-6. PubMed ID: 5483689
[No Abstract] [Full Text] [Related]
15. New drugs for peptic ulcer.
Br Med J; 1980 Jul; 281(6233):95-6. PubMed ID: 6107146
[No Abstract] [Full Text] [Related]
16. [Duodenal peptic ulcer. Medical therapy].
Villalobos Pérez JJ
Rev Gastroenterol Mex; 1984; 49(3):179-84. PubMed ID: 6151237
[No Abstract] [Full Text] [Related]
17. [Ranitidin--in cimetidine's foot steps].
Cohen L; Eshchar J
Harefuah; 1982 Jun; 102(12):543-7. PubMed ID: 6131019
[No Abstract] [Full Text] [Related]
18. Effects of ranitidine or nocloprost on the selected gastric juice components in the patients with the gastric ulcer.
Skrodzka D; Gabryelewicz A
Rocz Akad Med Bialymst; 1997; 42(1):257-66. PubMed ID: 9581490
[TBL] [Abstract][Full Text] [Related]
19. [Peptic ulcer: current therapy].
Pieragnoli E
G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387
[No Abstract] [Full Text] [Related]
20. Pirenzepine in long-term therapy for duodenal ulcer.
Capria A; Bresci G; Polloni A; Rindi G; Geloni M; Del Tacca M
Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):422-4. PubMed ID: 6688799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
